The use of processed electroencephalography (pEEG) in obstetric anaesthesia: a narrative review

Corner, H.; Barley, M.; Metodiev, Yavor

doi:10.1016/j.ijoa.2023.103650

Cited by 3 publications

(1 citation statement)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of processed electroencephalography (pEEG) monitoring during TIVA with neuromuscular blocking agents is recommended [ 25 ] and 102/104 (98%) patients in our evaluation had pEEG monitoring placed during TIVA (Table 2 ). However, the physiological changes of pregnancy and obstetric pathology such as preeclampsia may influence EEG activity and interpretation, which has not been well characterised in the literature [ 26 ]. Nevertheless, TIVA has the theoretical advantage of reducing the incidence of accidental awareness under GA by avoiding the ‘gap’ between intravenous induction and the onset of volatile anaesthesia [ 27 ], although whether this advantage would be delivered in practice is unknown.…”

Section: Discussionmentioning

confidence: 99%

ObsTIVA‐UK: a service evaluation of obstetric total intravenous anaesthesia in the United Kingdom

Metodiev,

Iliff,

Sharif

et al. 2024

Anaesthesia Reports

Self Cite

View full text Add to dashboard Cite

SummaryWe conducted a prospective observational service evaluation across the United Kingdom on the use of total intravenous anaesthesia (TIVA) for obstetric surgery between November 2022 and June 2023. The primary aim was to describe the incidence of TIVA for obstetric surgery within participating units, with secondary aims to describe maternal and neonatal postoperative recovery indicators. Of 184 maternity units in the United Kingdom, 30 (16%) contributed data to the service evaluation. There were 104 patients who underwent caesarean delivery under TIVA and 19 patients had TIVA for other reasons. Infusions of propofol and remifentanil were used in 100% and 84% of cases, respectively. Fifty‐nine out of 103 live neonates (57%) required some form of respiratory support. Of the neonates with recorded data, 73% and 17% had Apgar scores < 7 at 1 and 5 min respectively. No neonates were recorded to have Apgar scores < 7 at 10 min. Further prospective research is required to investigate the impact of obstetric TIVA on maternal and neonatal outcomes and inform best practice recommendations.

show abstract

Section: Discussionmentioning

confidence: 99%